BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 2 filers reported holding BIOPHARMX CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,000 | -75.0% | 12,264 | -70.1% | 0.00% | – |
Q4 2018 | $4,000 | -84.0% | 40,964 | -69.0% | 0.00% | – |
Q3 2018 | $25,000 | -26.5% | 132,060 | -14.5% | 0.00% | – |
Q2 2018 | $34,000 | -19.0% | 154,402 | -14.9% | 0.00% | – |
Q1 2018 | $42,000 | +366.7% | 181,335 | +469.1% | 0.00% | – |
Q3 2017 | $9,000 | -81.2% | 31,866 | +0.2% | 0.00% | – |
Q4 2015 | $48,000 | – | 31,789 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 16,128,515 | $1,740,000 | 0.22% |
FRG Family Wealth Advisors LLC | 30,000 | $3,000 | 0.00% |
LEVEL FOUR ADVISORY SERVICES, LLC | 66,933 | $7,000 | 0.00% |
Chicago Partners Investment Group LLC | 32,462 | $4,000 | 0.00% |
Virtu Financial LLC | 98,004 | $11,000 | 0.00% |
NORTHERN TRUST CORP | 92,518 | $10,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 1,343,372 | $144,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 25,349 | $3,000 | 0.00% |
OPPENHEIMER & CO INC | 25,000 | $3,000 | 0.00% |